Cellarity
The Cellarity platform provides critical insights into cellular dysfunction and reveals new biology that we can use to treat disease.
$121M Series B+ ·
Source: fundraisingfox.com
Latest round on record: Series B+, November 2024, amount undisclosed.
All 2 rounds ↓Acquired by EEtcelera on .
Signals
Cellarity | 1332 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- Acquired by
EEtcelera
- Series B+ · amount undisclosedSource: fundraisingfox.com
- Series B+ · $121MSource: fundraisingfox.com
- X account created
- Website created
Founders and team
AK
Avak Kahvejian FounderJC
Jim Collins FounderNP
Nick Plugis FounderNA
Noubar Afeyan FounderCN
Chad Nusbaum Chief Technology OfficerDR
David Risinger CFOJL
John Leaman Chief Financial Officer
Investors
BBlackRock
FFlagship Pioneering
HHanwha Impact Partners
KKyowa Kirin
PPictet Private Equity Investors S.A.
TThe Baupost Group
Companies like Cellarity
CChronicleBio
PPretzel TherapeuticsSeries A · Sep 2022
RRetrotopeSeries B+ · Aug 2021NNewLimit$435M Series B+ · Jun 2026
BBioAge Labs
NNula Therapeutics$20M Seed · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cellarity (get a free API key).